Pharmacytimes: Condition Center: Mental Health http://www.pharmacytimes.com/condition-resources/mental-health/condition-rss Mental Health en-us Mon, 23 Jul 2018 11:46:19 UTC Mon, 23 Jul 2018 11:46:19 UTC Fluoroquinolone Warnings for Mental Health, Hypoglycemia Risks are Updated http://www.pharmacytimes.com/resource-centers/mental-health/fluoroquinolone-warnings-for-mental-health-hypoglycemia-risks-are-updated Officials with the FDA are requiring safety label updates for fluoroquinolone antibiotics due to risks of mental health adverse effects, and blood sugar disturbances. 11:00 AM, Wed July 11, 2018 Schizophrenia Regimen Approved by FDA http://www.pharmacytimes.com/resource-centers/mental-health/schizophrenia-regimen-approved-by-fda Officials with the FDA have approved an Alkermes aripiprazole lauroxil (Aristada Initio) extended-release product for the treatment of schizophrenia in adults, according to the company. 5:18 PM, Mon July 2, 2018 5 Ways Pharmacists Can Help Prevent Suicide http://www.pharmacytimes.com/news/5-ways-pharmacists-can-help-prevent-suicide The deaths this week of Kate Spade and&nbsp;Anthony Bourdain have sparked a much-needed public discussion about mental health and suicide can be prevented. 2:00 PM, Fri June 8, 2018 A Video Game to Create Empathy http://www.pharmacytimes.com/contributor/alex-barker-pharmd/2018/05/a-video-game-to-create-empathy This adult fantasy game provides a first-hand view of psychosis and the symptoms its patients often experience. 12:59 AM, Thu May 10, 2018 Dextromethorphan Studied for Use In Bipolar Disorder http://www.pharmacytimes.com/contributor/shivam-patel-pharmd-candidate/2018/05/dextromethorphan-studied-for-use-in-bipolar-disorder Dextromethorphan neuroprotective characteristics may play a role in patients with bipolar disorder. 12:23 PM, Tue May 8, 2018 ASD and Medication Adherence: An Opportunity for Pharmacist Intervention http://www.pharmacytimes.com/resource-centers/mental-health/asd-and-medication-adherence-an-opportunity-for-pharmacist-intervention Unfortunately, medication adherence in children with ASD is poor, particularly among children with chronic conditions or comorbid mental health conditions. 1:43 AM, Wed March 14, 2018 FDA OKs Lurasidone for Use as Bipolar Medication in Children http://www.pharmacytimes.com/product-news/fda-oks-lurasidone-for-use-as-bipolar-medication-in-children Officials with the FDA have approved a supplemental new drug application (sNDA) to expand the use of lurasidone HCl (Latuda, Sunovion) to include the treatment of bipolar depression in pediatric patients (10 to 17 years of age). 7:00 AM, Wed March 7, 2018 The Science Behind Pharmacist Burnout Is Scary: Here Is What to Do About It http://www.pharmacytimes.com/contributor/alex-barker-pharmd/2018/01/the-science-behind-pharmacist-burnout-is-scary-heres-what-to-do-about-it Experts are finding, though, that burnout doesn&#39;t limit its impact to the workplace. It also impacts parts of your life that extend well beyond the pharmacy. 10:24 PM, Wed January 24, 2018 The Proven Health Benefits of Yoga and Meditation http://www.pharmacytimes.com/contributor/christina-tarantola/2018/01/the-surprising-ways-a-mindfulness-practice-can-improve-your-quality-of-life Discover how a mindfulness practice can improve a person&#39;s quality of life. 10:00 AM, Sat January 20, 2018 Allergan, Gedeon Richter Plan to Submit Cariprazine sNDA for Depression http://www.pharmacytimes.com/product-news/allergan-gedeon-richter-plan-to-submit-cariprazine-snda-for-depression Officials with Allergan and Gedeon Richter are reporting positive topline results for a phase 3 study of cariprazine (Vraylar) for the treatment of adults with bipolar I depression.<br /> &nbsp; 2:00 AM, Wed December 20, 2017 Perinatal HIV Infection: Nonadherence Risk Increases in Adolescents http://www.pharmacytimes.com/resource-centers/hiv/perinatal-hiv-infection-nonadherence-risk-increases-in-adolescents Adolescents and young adults who are living with HIV and were exposed to the virus perinatally have a unique risk of nonadherence in adolescence, as well as an elevated risk of mental health and substance use problems.&nbsp; 10:20 AM, Fri December 15, 2017 Stressed Out At Work? Ways to Cope with Challenges http://www.pharmacytimes.com/contributor/karen-berger/2017/11/stressed-out-at-work-ways-to-cope-with-challenges Here are some ways to cope with any stress or challenges that community pharmacy may bring. 4:46 AM, Wed November 29, 2017 What the WHO Essentials List Means for Mental Health http://www.pharmacytimes.com/resource-centers/mental-health/what-the-who-essentials-list-means-for-mental-health- One glaring omission is the lack of psychiatric medications included.<br /> &nbsp; 8:00 AM, Fri November 24, 2017 What Pharmacists Should Know About the Abilify MyCite Pill http://www.pharmacytimes.com/contributor/timothy-aungst-pharmd/2017/11/what-you-need-to-know-about-the-abilify-mycite-pill With the smart tablets coming to market in 2018, it is a good time to explore how the technology behind the product works. 2:34 AM, Fri November 17, 2017 10 Natural Remedies to Consider for Treating Anxiety http://www.pharmacytimes.com/contributor/cate-sibley-pharmd/2017/10/10-natural-remedies-to-consider-for-treating-anxiety Here is how to go beyond conventional medicine to help those who suffer from the leading mental health disorder in the United States. 12:06 AM, Thu October 26, 2017 5 Psychiatry Studies Pharmacists Should Know About http://www.pharmacytimes.com/contributor/timothy-o-shea/2017/09/5-psychiatry-studies-pharmacists-should-know-about Over the years, a number of landmark clinical studies in the field of psychiatry have been published, shaping how we treat mental illness. Here are 5 that every pharmacist should know about. 3:47 AM, Wed September 20, 2017 Pharmacists Can Play Important Role in Depression Screening http://www.pharmacytimes.com/publications/issue/2017/August2017/pharmacists-can-play-important-role-in-depression-screening According to the US Preventive Services Task Force&#39;s (USPSTF) updated recommendations for depression screening in adults, major depressive disorder is the leading cause of disability among adults in high-income countries. 3:10 PM, Sun September 3, 2017 What is the National Council on Patient Information and Education? http://www.pharmacytimes.com/contributor/steve-leuck-pharmd/2017/08/what-is-the-national-council-on-patient-information-and-education Here is the 411 on this organization, which offers programs to help consumers better understand their medications. 11:36 PM, Wed August 23, 2017 Management of Psychosis in Parkinson's Disease: Clinical Tidbits http://www.pharmacytimes.com/contributor/chris-tanski-pharmd/2017/05/management-of-psychosis-in-parkinsons-disease-clinical-tidbits What are the best practice considerations for managing Parkinson's Psychosis? 11:26 PM, Tue May 9, 2017 Carving Out a Niche in the Treatment of Tardive Dyskinesia http://www.pharmacytimes.com/contributor/austin-hewlett-pharmd-mba-candidate/2017/05/carving-out-a-niche-in-the-treatment-of-tardive-dyskinesia The FDA recently approved Ingrezza (valbenazine) for the treatment of adults with tardive dyskinesia. 1:33 AM, Wed May 3, 2017